Citation 105642

ROJO,HP: UUIROGA,EN: VATTUONE,MA: SAMPIETRO,AR:. (1997). THE EFFECTS OF SELECTION OF ALKALOIDS ON THE INVERTASE ACTIVITY OF SOME HIGHER PLANTS.. 43(6)

Citation Details

Title	THE EFFECTS OF SELECTION OF ALKALOIDS ON THE INVERTASE ACTIVITY OF SOME HIGHER PLANTS.
Authors	ROJO,HP: UUIROGA,EN: VATTUONE,MA: SAMPIETRO,AR:
Year	1997
Volume	43
Issue	6

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STRYCHNINE	WEAK ACTIVITY
2	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STRYCHNINE	ACTIVE
3	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STRYCHNINE	ACTIVE
4	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STRYCHNINE	WEAK ACTIVITY
5	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COCAINE	INACTIVE
6	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COCAINE	INACTIVE
7	INVERTASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	COCAINE	ACTIVE
8	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COCAINE	INACTIVE
9	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PAPAVERINE	INACTIVE
10	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PAPAVERINE	WEAK ACTIVITY
11	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PAPAVERINE	WEAK ACTIVITY
12	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PAPAVERINE	INACTIVE
13	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORPHINE	WEAK ACTIVITY
14	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORPHINE	WEAK ACTIVITY
15	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORPHINE	WEAK ACTIVITY
16	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORPHINE	WEAK ACTIVITY
17	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEINE	WEAK ACTIVITY
18	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEINE	INACTIVE
19	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEINE	INACTIVE
20	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEINE	INACTIVE
21	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BERBERINE	INACTIVE
22	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BERBERINE	INACTIVE
23	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BERBERINE	ACTIVE
24	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BERBERINE	WEAK ACTIVITY
25	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NICOTINE	INACTIVE
26	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NICOTINE	INACTIVE
27	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NICOTINE	WEAK ACTIVITY
28	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NICOTINE	INACTIVE
29	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NICOTINE,NOR:	INACTIVE
30	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NICOTINE,NOR:	INACTIVE
31	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NICOTINE,NOR:	INACTIVE
32	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NICOTINE,NOR:	INACTIVE
33	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANABASINE	INACTIVE
34	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANABASINE	INACTIVE
35	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANABASINE	INACTIVE
36	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANABASINE	INACTIVE
37	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ATROPINE	INACTIVE
38	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ATROPINE	INACTIVE
39	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ATROPINE	INACTIVE
40	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ATROPINENARCEINE,ETHYL:	INACTIVE
41	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORPHINE,APO:	INACTIVE
42	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORPHINE,APO:	INACTIVE
43	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORPHINE,APO:	INACTIVE
44	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORPHINE,APO:	WEAK ACTIVITY
45	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CODEINE	INACTIVE
46	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CODEINE	WEAK ACTIVITY
47	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CODEINE	WEAK ACTIVITY
48	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CODEINE	INACTIVE
49	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARCEINE,ETHYL:	WEAK ACTIVITY
50	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARCEINE,ETHYL:	WEAK ACTIVITY
51	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARCEINE,ETHYL:	INACTIVE
52	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARCEINE,ETHYL:	INACTIVE
53	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUININE	INACTIVE
54	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUININE	INACTIVE
55	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUININE	INACTIVE
56	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUININE	INACTIVE
57	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIDINE	WEAK ACTIVITY
58	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIDINE	WEAK ACTIVITY
59	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIDINE	ACTIVE
60	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIDINE	INACTIVE
61	INVERTASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	SOLANINE,ALPHA:	ACTIVE
62	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SOLANINE,ALPHA:	WEAK ACTIVITY
63	INVERTASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	SOLANINE,ALPHA:	ACTIVE
64	INVERTASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	SOLANINE,ALPHA:	ACTIVE
65	INVERTASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	SOLANIDINE	ACTIVE
66	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SOLANIDINE	WEAK ACTIVITY
67	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SOLANIDINE	WEAK ACTIVITY
68	INVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SOLANIDINE	WEAK ACTIVITY

Citation 105642

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1